Lauren Epstein

5.3k total citations · 2 hit papers
45 papers, 2.5k citations indexed

About

Lauren Epstein is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Lauren Epstein has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 15 papers in Infectious Diseases and 10 papers in Applied Microbiology and Biotechnology. Recurrent topics in Lauren Epstein's work include Sepsis Diagnosis and Treatment (11 papers), Antibiotic Use and Resistance (10 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Lauren Epstein is often cited by papers focused on Sepsis Diagnosis and Treatment (11 papers), Antibiotic Use and Resistance (10 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Lauren Epstein collaborates with scholars based in United States, Colombia and Hong Kong. Lauren Epstein's co-authors include Raymund Dantes, Chanu Rhee, Michael Klompas, Anthony E. Fiore, John A. Jernigan, David K. Warren, David J. Murphy, Derek C. Angus, Sameer S. Kadri and Greg S. Martin and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Lauren Epstein

41 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

2017 1.2k citations Chanu Rhee, Raymund Dantes et al. JAMA profile →
Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals

2019 363 citations Chanu Rhee, Travis Jones et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren Epstein United States	17	1.6k	591	350	276	266	45	2.5k
Raymund Dantes United States	18	1.7k 1.0×	576 1.0×	394 1.1×	590 2.1×	264 1.0×	33	2.7k
David J. Murphy United States	19	1.2k 0.8×	656 1.1×	329 0.9×	327 1.2×	322 1.2×	56	2.5k
Michael A. Puskarich United States	31	1.7k 1.0×	631 1.1×	607 1.7×	265 1.0×	653 2.5×	117	3.2k
Susan Gruber United States	22	1.2k 0.7×	351 0.6×	272 0.8×	216 0.8×	185 0.7×	59	3.1k
Rahul Nanchal United States	27	1.1k 0.7×	508 0.9×	575 1.6×	183 0.7×	360 1.4×	72	2.5k
Christopher Seymour United States	28	2.4k 1.5×	838 1.4×	577 1.6×	221 0.8×	743 2.8×	61	3.7k
David T. Huang United States	31	1.4k 0.9×	559 0.9×	499 1.4×	178 0.6×	594 2.2×	89	3.4k
Fabián Jaimes Colombia	22	1.0k 0.6×	351 0.6×	348 1.0×	178 0.6×	219 0.8×	151	2.1k
Θωμάς Τσαγανός Greece	20	2.1k 1.3×	708 1.2×	504 1.4×	217 0.8×	193 0.7×	66	3.5k
Juan González del Castillo Spain	28	1.1k 0.7×	354 0.6×	357 1.0×	460 1.7×	325 1.2×	271	3.5k

Countries citing papers authored by Lauren Epstein

Since Specialization

Citations

This map shows the geographic impact of Lauren Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Epstein more than expected).

Fields of papers citing papers by Lauren Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Epstein. The network helps show where Lauren Epstein may publish in the future.

Co-authorship network of co-authors of Lauren Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Epstein. A scholar is included among the top collaborators of Lauren Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Epstein. Lauren Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Brigid, Michael J. Satlin, Federico Pérez, et al.. (2024). 14-Year Epidemiologic study of Pseudomonas aeruginosa bloodstream infection incidence and resistance in the Veterans Health Administration system, 2009–2022. JAC-Antimicrobial Resistance. 6(2). dlae031–dlae031. 3 indexed citations

Epstein, Lauren. (2023). VA SHIELD: A Biorepository for Veterans and the Nation. Federal Practitioner. 40(Suppl 5). S48–S51. 1 indexed citations

Young‐Xu, Yinong, Lauren Epstein, Vincent C. Marconi, et al.. (2023). Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data. mBio. 14(4). e0102423–e0102423. 12 indexed citations

Young‐Xu, Yinong, Caroline Korves, Carolina Reyes, et al.. (2023). Effectiveness of Sotrovimab in Preventing COVID-19-Related Hospitalizations or Deaths Among US Veterans During Omicron BA.1. Open Forum Infectious Diseases. 10(12). ofad605–ofad605. 5 indexed citations

Epstein, Lauren, Daniel J. Diekema, Daniel J. Morgan, et al.. (2023). Diagnostic stewardship and the coronavirus disease 2019 (COVID-19) pandemic: Lessons learned for prevention of emerging infectious diseases in acute-care settings. Infection Control and Hospital Epidemiology. 45(3). 277–283. 2 indexed citations

McKinsey, David S., Joel P. McKinsey, Paula Snippes Vagnone, et al.. (2021). A comprehensive approach to ending an outbreak of rare bla gene-positive carbapenem-resistant Acinetobacter baumannii at a Community Hospital, Kansas City, MO, 2018. American Journal of Infection Control. 49(9). 1183–1185. 2 indexed citations

Bardossy, Ana C., Emily A. Snavely, Elizabeth Nazarian, et al.. (2020). Donor‐derived transmission through lung transplantation of carbapenem‐resistant Acinetobacter baumannii producing the OXA‐23 carbapenemase during an ongoing healthcare facility outbreak. Transplant Infectious Disease. 22(2). e13256–e13256.

Gomes, Danica, Ana C. Bardossy, Lei Chen, et al.. (2020). Transmission of novel Klebsiella pneumoniae carbapenemase-producing Escherichia coli sequence type 1193 among residents and caregivers in a community-based, residential care setting—Nevada, 2018. Infection Control and Hospital Epidemiology. 41(11). 1341–1343. 7 indexed citations

Benowitz, Isaac, Heather Moulton-Meissner, Lauren Epstein, & Matthew J. Arduino. (2020). Gastrointestinal Flexible Endoscopes: Infection Control Risks, Lessons Learned from Outbreaks, and Centers for Disease Control and Prevention Guidance. Gastrointestinal Endoscopy Clinics of North America. 30(4). 723–733. 8 indexed citations

10.

Rhee, Chanu, Travis Jones, Yasir Hamad, et al.. (2019). Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Network Open. 2(2). e187571–e187571. 363 indexed citations breakdown →

11.

Rhee, Chanu, Raymund Dantes, Lauren Epstein, et al.. (2017). Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 318(13). 1241–1241. 1214 indexed citations breakdown →

12.

See, Isaac, Minn Soe, Lauren Epstein, et al.. (2016). Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line–associated bloodstream infection rates in the National Healthcare Safety Network, 2014. American Journal of Infection Control. 45(3). 321–323. 16 indexed citations

13.

Baggs, James, et al.. (2016). Increased Risk of Sepsis During Hospital Readmission Following Exposure to Certain Antibiotics During Hospitalization. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations

14.

Epstein, Lauren, Nimalie D. Stone, Jane Harper, et al.. (2016). Comparison of Data Collection for Healthcare-Associated Infection Surveillance in Nursing Homes. Infection Control and Hospital Epidemiology. 37(12). 1440–1445. 7 indexed citations

15.

Epstein, Lauren, Yi Mu, Ruth Belflower, et al.. (2015). Risk Factors for Invasive Methicillin-ResistantStaphylococcus aureusInfection After Recent Discharge From an Acute-Care Hospitalization, 2011–2013. Clinical Infectious Diseases. 62(1). 45–52. 27 indexed citations

16.

Muldoon, Eavan G., Lauren Epstein, Tanya Logvinenko, et al.. (2013). The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients. Anaerobe. 24. 79–81. 14 indexed citations

17.

Hong, Steven Y., Lauren Epstein, Kenneth Lawrence, et al.. (2012). Evaluation of programmatic changes to an antimicrobial stewardship program with house officer feedback. Journal of Evaluation in Clinical Practice. 19(2). 388–392. 4 indexed citations

18.

Epstein, Lauren & Yoav Golan. (2012). Fidaxomicin, a new treatment for Clostridium difficile infections. Drugs of today. 48(2). 101–101. 3 indexed citations

19.

Laws, M. Barton, Lauren Epstein, Yoojin Lee, et al.. (2011). The association of visit length and measures of patient-centered communication in HIV care: A mixed methods study. Patient Education and Counseling. 85(3). e183–e188. 26 indexed citations

20.

Goldberg, A.David, Lauren Epstein, & Brian W. Pickering. (2010). Pyopneumopericardium Due to Group F Streptococci. CHEST Journal. 138(4). 83A–83A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact